A Major GLP-1 Drug Shortage Is Over. Some Patients Aren’t Celebrating

Quick Summary:

Mounjaro and Zepbound are now out of shortage.

This should be good news—but because so many patients are taking compounded versions of these GLP-1 medications, it’s a complicated situation.

Despite the introduction of this product, many people who have been taking compounded tirzepatide say they won’t be able to afford the name-brand version, even if it is readily available.“It is simply financially inaccessible,” Bertel says.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: Kate Knibbs

Category: TechnologyEconomy

Markets: United States

Topics: Science Science / Health

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-10-09 @ 11:30:00 (10 hours ago)

News Timezone: GMT +8:00

News Source URL: wired.com

Language: English

Article Length: 1983 words

Reading Time: 12 minutes read

Sentences: 71 lines

Sentence Length: 28 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Wired

News ID: 22968057

View Article Analysis

About Wired

Main Topics: TechnologyEconomy

Official Website: wired.com

Update Frequency: 10 posts per day

Year Established: 1993

Headquarters: United States

News Last Updated: 9 hours ago

Coverage Areas: United States

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #111

Publisher Details

Frequently Asked Questions